Rank | Gene Set | Z-score |
---|---|---|
1 | * antibacterial humoral response (GO:0019731) | 9.52078668 |
2 | leukocyte aggregation (GO:0070486) | 9.17501329 |
3 | * antimicrobial humoral response (GO:0019730) | 8.86596669 |
4 | * mucosal immune response (GO:0002385) | 8.37249053 |
5 | * organ or tissue specific immune response (GO:0002251) | 7.77065764 |
6 | detection of bacterium (GO:0016045) | 6.80352806 |
7 | sequestering of metal ion (GO:0051238) | 6.72490645 |
8 | detection of other organism (GO:0098543) | 6.49183144 |
9 | * defense response to fungus (GO:0050832) | 6.35852890 |
10 | response to peptidoglycan (GO:0032494) | 6.28199332 |
11 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 6.25279219 |
12 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 6.25279219 |
13 | neutrophil activation involved in immune response (GO:0002283) | 5.71242638 |
14 | intracellular estrogen receptor signaling pathway (GO:0030520) | 5.56487835 |
15 | regulation of female gonad development (GO:2000194) | 5.49995165 |
16 | macrophage differentiation (GO:0030225) | 5.11434698 |
17 | respiratory burst (GO:0045730) | 5.10510349 |
18 | * response to fungus (GO:0009620) | 5.08134418 |
19 | cellular extravasation (GO:0045123) | 5.06996873 |
20 | cell killing (GO:0001906) | 5.06490725 |
21 | citrulline biosynthetic process (GO:0019240) | 5.04495861 |
22 | positive regulation of steroid hormone secretion (GO:2000833) | 5.01226253 |
23 | chronic inflammatory response (GO:0002544) | 4.98066817 |
24 | neutrophil activation (GO:0042119) | 4.98001438 |
25 | pentose-phosphate shunt (GO:0006098) | 4.97573368 |
26 | neutrophil mediated immunity (GO:0002446) | 4.69697305 |
27 | disruption of cells of other organism (GO:0044364) | 4.59482224 |
28 | killing of cells of other organism (GO:0031640) | 4.59482224 |
29 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.52277944 |
30 | NADPH regeneration (GO:0006740) | 4.49185280 |
31 | granulocyte activation (GO:0036230) | 4.47181960 |
32 | neutrophil chemotaxis (GO:0030593) | 4.40250081 |
33 | cellular response to interleukin-6 (GO:0071354) | 4.36217192 |
34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.28440026 |
35 | neutrophil migration (GO:1990266) | 4.27835430 |
36 | response to methylmercury (GO:0051597) | 4.26045629 |
37 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.19320623 |
38 | hepatocyte differentiation (GO:0070365) | 4.16655517 |
39 | interferon-gamma secretion (GO:0072643) | 4.12728085 |
40 | endodermal cell differentiation (GO:0035987) | 4.08795234 |
41 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.08332130 |
42 | superoxide anion generation (GO:0042554) | 4.02495322 |
43 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.01574867 |
44 | diterpenoid biosynthetic process (GO:0016102) | 3.99227607 |
45 | positive regulation of vesicle fusion (GO:0031340) | 3.95996887 |
46 | positive regulation of p38MAPK cascade (GO:1900745) | 3.93706294 |
47 | detection of external biotic stimulus (GO:0098581) | 3.87244278 |
48 | regulation of leukocyte degranulation (GO:0043300) | 3.87216495 |
49 | negative regulation of interleukin-6 production (GO:0032715) | 3.83539606 |
50 | regulation of regulated secretory pathway (GO:1903305) | 3.81995214 |
51 | granulocyte migration (GO:0097530) | 3.80276343 |
52 | regulation of natural killer cell differentiation (GO:0032823) | 3.78838936 |
53 | reactive oxygen species biosynthetic process (GO:1903409) | 3.77011674 |
54 | hemidesmosome assembly (GO:0031581) | 3.75128210 |
55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.72254886 |
56 | response to interleukin-6 (GO:0070741) | 3.72234322 |
57 | granulocyte chemotaxis (GO:0071621) | 3.70123610 |
58 | * negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.65057526 |
59 | negative regulation of tumor necrosis factor production (GO:0032720) | 3.65057526 |
60 | glucose catabolic process (GO:0006007) | 3.56083157 |
61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.55710050 |
62 | negative regulation of cell killing (GO:0031342) | 3.55710050 |
63 | positive regulation of mast cell activation (GO:0033005) | 3.55302828 |
64 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.51237162 |
65 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.51237162 |
66 | response to manganese ion (GO:0010042) | 3.48922794 |
67 | defense response to Gram-positive bacterium (GO:0050830) | 3.48168022 |
68 | myeloid leukocyte mediated immunity (GO:0002444) | 3.47655746 |
69 | * response to bacterium (GO:0009617) | 3.47109684 |
70 | oxygen transport (GO:0015671) | 3.46753390 |
71 | hemoglobin metabolic process (GO:0020027) | 3.43463702 |
72 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.32620402 |
73 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.32287674 |
74 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.28725344 |
75 | leukocyte cell-cell adhesion (GO:0007159) | 3.28068329 |
76 | leukocyte degranulation (GO:0043299) | 3.27255752 |
77 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.26764441 |
78 | growth hormone receptor signaling pathway (GO:0060396) | 3.25458284 |
79 | regulation of mast cell activation (GO:0033003) | 3.25378642 |
80 | detection of biotic stimulus (GO:0009595) | 3.23026584 |
81 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.21037739 |
82 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.19571574 |
83 | regulation of feeding behavior (GO:0060259) | 3.17898164 |
84 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.16471752 |
85 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.15235557 |
86 | regulation of growth of symbiont in host (GO:0044126) | 3.15235557 |
87 | negative regulation of growth of symbiont in host (GO:0044130) | 3.15235557 |
88 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.15235557 |
89 | positive regulation of lamellipodium assembly (GO:0010592) | 3.14426380 |
90 | cell wall macromolecule catabolic process (GO:0016998) | 3.10926522 |
91 | opsonization (GO:0008228) | 3.10497521 |
92 | positive regulation of regulated secretory pathway (GO:1903307) | 3.07954540 |
93 | defense response to Gram-negative bacterium (GO:0050829) | 3.06680099 |
94 | modification of morphology or physiology of other organism (GO:0035821) | 3.03748767 |
95 | regulation of steroid hormone secretion (GO:2000831) | 3.02577988 |
96 | macrophage activation involved in immune response (GO:0002281) | 3.01359580 |
97 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.98788074 |
98 | leukotriene metabolic process (GO:0006691) | 2.97683401 |
99 | NADP metabolic process (GO:0006739) | 2.97487430 |
100 | * phagosome maturation (GO:0090382) | 2.97144633 |
101 | activated T cell proliferation (GO:0050798) | 2.96066037 |
102 | myeloid cell development (GO:0061515) | 2.95629932 |
103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95621944 |
104 | negative regulation of phagocytosis (GO:0050765) | 2.94041156 |
105 | citrulline metabolic process (GO:0000052) | 2.93807611 |
106 | 4-hydroxyproline metabolic process (GO:0019471) | 2.93694216 |
107 | regulation of macrophage activation (GO:0043030) | 2.92455433 |
108 | regulation of receptor binding (GO:1900120) | 2.91069481 |
109 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.90495200 |
110 | modification by host of symbiont morphology or physiology (GO:0051851) | 2.90289452 |
111 | positive regulation by symbiont of host defense response (GO:0052509) | 2.86868533 |
112 | modulation by symbiont of host defense response (GO:0052031) | 2.86868533 |
113 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.86868533 |
114 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.86868533 |
115 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.86868533 |
116 | modulation by symbiont of host immune response (GO:0052553) | 2.86868533 |
117 | regulation of mast cell degranulation (GO:0043304) | 2.86851068 |
118 | * defense response to bacterium (GO:0042742) | 2.86291233 |
119 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.85284034 |
120 | myeloid leukocyte migration (GO:0097529) | 2.85106236 |
121 | positive regulation of leukocyte degranulation (GO:0043302) | 2.84321366 |
122 | embryonic process involved in female pregnancy (GO:0060136) | 2.84130402 |
123 | detection of molecule of bacterial origin (GO:0032490) | 2.83715658 |
124 | regulation of p38MAPK cascade (GO:1900744) | 2.83060477 |
125 | keratinocyte differentiation (GO:0030216) | 2.82173951 |
126 | regulation of interleukin-8 secretion (GO:2000482) | 2.81721702 |
127 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.81661886 |
128 | glucosamine-containing compound catabolic process (GO:1901072) | 2.78368147 |
129 | terpenoid biosynthetic process (GO:0016114) | 2.77722215 |
130 | one-carbon compound transport (GO:0019755) | 2.76671750 |
131 | positive regulation of mast cell degranulation (GO:0043306) | 2.75300156 |
132 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75300156 |
133 | gas transport (GO:0015669) | 2.74567328 |
134 | amino sugar catabolic process (GO:0046348) | 2.72597698 |
135 | leukotriene biosynthetic process (GO:0019370) | 2.72380682 |
136 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.72350123 |
137 | cellular response to growth hormone stimulus (GO:0071378) | 2.72328345 |
138 | negative regulation of interleukin-8 production (GO:0032717) | 2.70929295 |
139 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.70921865 |
140 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.69841212 |
141 | interaction with symbiont (GO:0051702) | 2.69237671 |
142 | keratinization (GO:0031424) | 2.69232367 |
143 | regulation of phagocytosis (GO:0050764) | 2.69197876 |
144 | homotypic cell-cell adhesion (GO:0034109) | 2.66392103 |
145 | regulation of respiratory burst (GO:0060263) | 2.66140100 |
146 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.65745086 |
147 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.65745086 |
148 | regulation of podosome assembly (GO:0071801) | 2.65489679 |
149 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.61283742 |
150 | * innate immune response in mucosa (GO:0002227) | 10.3530014 |
151 | leukocyte migration involved in inflammatory response (GO:0002523) | 10.3202512 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.34749485 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.20776020 |
3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.68935426 |
4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.55775002 |
5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.13014344 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87983484 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.82953077 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80696287 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.79051329 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.78113974 |
11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.71609196 |
12 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.57771848 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48428844 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47466919 |
15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.37685088 |
16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.28114741 |
17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21688745 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.21073917 |
19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.14755496 |
20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.13919541 |
21 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.09839466 |
22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07439594 |
23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.05120455 |
24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.03927371 |
25 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00633745 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91330271 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.85510803 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81521546 |
29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74360762 |
30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71915055 |
31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71835219 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65998874 |
33 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64639891 |
34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64039260 |
35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63918702 |
36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63187814 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61272366 |
38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.60250059 |
39 | MYB_26560356_Chip-Seq_TH2_Human | 1.60090021 |
40 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59316532 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58152546 |
42 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.57345531 |
43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.57345531 |
44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.57336602 |
45 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.57013765 |
46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55885968 |
47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53134635 |
48 | MAF_26560356_Chip-Seq_TH1_Human | 1.51486497 |
49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.49454023 |
50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.48334695 |
51 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48304105 |
52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46197096 |
53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45065088 |
54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44566771 |
55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44548382 |
56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44002798 |
57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43013695 |
58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42263933 |
59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41764202 |
60 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.40645356 |
61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39887258 |
62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39215511 |
63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39146447 |
64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35735443 |
65 | GATA2_19941826_ChIP-Seq_K562_Human | 1.35551947 |
66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35182677 |
67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33404551 |
68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33350920 |
69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33327101 |
70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33292923 |
71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32328771 |
72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32071391 |
73 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31414221 |
74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30025928 |
75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29124238 |
76 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28345382 |
77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26738092 |
78 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26615000 |
79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25453373 |
80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.25054407 |
81 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22841167 |
82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21876357 |
83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21490132 |
84 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.21433751 |
85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19258260 |
86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17485237 |
87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16679016 |
88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16634664 |
89 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.16565720 |
90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14442614 |
91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14128301 |
92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14014538 |
93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13686078 |
94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12092768 |
95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10707800 |
96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10570087 |
97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09533157 |
98 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09245179 |
99 | MAF_26560356_Chip-Seq_TH2_Human | 1.08579347 |
100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08399142 |
101 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08187584 |
102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08063076 |
103 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.07773372 |
104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07447864 |
105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06543238 |
106 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06140123 |
107 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06121593 |
108 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.05631481 |
109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04588141 |
110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04359273 |
111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04067833 |
112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03390164 |
113 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.03100908 |
114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02428817 |
115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02043634 |
116 | MYB_26560356_Chip-Seq_TH1_Human | 1.01631330 |
117 | MYC_22102868_ChIP-Seq_BL_Human | 1.01467000 |
118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01132250 |
119 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00823444 |
120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99297825 |
121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99168607 |
122 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99026319 |
123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98800023 |
124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98693914 |
125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97939590 |
126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97771839 |
127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95213222 |
128 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95131596 |
129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93395440 |
130 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90681280 |
131 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89854969 |
132 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88556794 |
133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87558602 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 5.11067386 |
2 | MP0010234_abnormal_vibrissa_follicle | 4.62977353 |
3 | MP0003436_decreased_susceptibility_to | 4.51176249 |
4 | MP0009785_altered_susceptibility_to | 3.69415130 |
5 | MP0009278_abnormal_bone_marrow | 3.58494764 |
6 | MP0002837_dystrophic_cardiac_calcinosis | 2.87527635 |
7 | MP0002419_abnormal_innate_immunity | 2.86644867 |
8 | MP0003183_abnormal_peptide_metabolism | 2.71445321 |
9 | MP0005167_abnormal_blood-brain_barrier | 2.63881535 |
10 | MP0003566_abnormal_cell_adhesion | 2.58209630 |
11 | MP0003300_gastrointestinal_ulcer | 2.42199661 |
12 | MP0001533_abnormal_skeleton_physiology | 2.37582150 |
13 | MP0004147_increased_porphyrin_level | 2.27171824 |
14 | MP0005025_abnormal_response_to | 2.19959358 |
15 | MP0008260_abnormal_autophagy | 2.18652194 |
16 | MP0000343_altered_response_to | 2.11049658 |
17 | MP0003075_altered_response_to | 2.03108977 |
18 | MP0001853_heart_inflammation | 1.98386151 |
19 | MP0005023_abnormal_wound_healing | 1.90561414 |
20 | MP0004883_abnormal_blood_vessel | 1.88807272 |
21 | MP0006054_spinal_hemorrhage | 1.87357200 |
22 | MP0000858_altered_metastatic_potential | 1.86396625 |
23 | MP0001851_eye_inflammation | 1.83858295 |
24 | MP0004264_abnormal_extraembryonic_tissu | 1.78575223 |
25 | MP0005397_hematopoietic_system_phenotyp | 1.73696544 |
26 | MP0001545_abnormal_hematopoietic_system | 1.73696544 |
27 | MP0002405_respiratory_system_inflammati | 1.73277123 |
28 | MP0003453_abnormal_keratinocyte_physiol | 1.72340239 |
29 | MP0003950_abnormal_plasma_membrane | 1.70625002 |
30 | MP0001881_abnormal_mammary_gland | 1.69325342 |
31 | MP0009764_decreased_sensitivity_to | 1.67487571 |
32 | MP0005464_abnormal_platelet_physiology | 1.64735498 |
33 | MP0005076_abnormal_cell_differentiation | 1.64421477 |
34 | MP0005164_abnormal_response_to | 1.57506060 |
35 | MP0000465_gastrointestinal_hemorrhage | 1.57303929 |
36 | MP0002166_altered_tumor_susceptibility | 1.53980798 |
37 | MP0000685_abnormal_immune_system | 1.49633148 |
38 | MP0001845_abnormal_inflammatory_respons | 1.48333355 |
39 | MP0004808_abnormal_hematopoietic_stem | 1.47358049 |
40 | MP0002452_abnormal_antigen_presenting | 1.46048568 |
41 | MP0004947_skin_inflammation | 1.44651348 |
42 | MP0003279_aneurysm | 1.44413776 |
43 | MP0001819_abnormal_immune_cell | 1.44207132 |
44 | MP0005000_abnormal_immune_tolerance | 1.43673656 |
45 | MP0002420_abnormal_adaptive_immunity | 1.43268481 |
46 | MP0010155_abnormal_intestine_physiology | 1.42809546 |
47 | MP0005166_decreased_susceptibility_to | 1.42248888 |
48 | MP0002933_joint_inflammation | 1.40441632 |
49 | MP0010678_abnormal_skin_adnexa | 1.40282043 |
50 | MP0002148_abnormal_hypersensitivity_rea | 1.40178732 |
51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.38619396 |
52 | MP0003448_altered_tumor_morphology | 1.38530648 |
53 | MP0004130_abnormal_muscle_cell | 1.37910094 |
54 | MP0002877_abnormal_melanocyte_morpholog | 1.37254452 |
55 | MP0003091_abnormal_cell_migration | 1.37125033 |
56 | MP0002254_reproductive_system_inflammat | 1.36545551 |
57 | MP0010352_gastrointestinal_tract_polyps | 1.32186914 |
58 | MP0001216_abnormal_epidermal_layer | 1.29854106 |
59 | MP0003724_increased_susceptibility_to | 1.29675040 |
60 | MP0001849_ear_inflammation | 1.29393604 |
61 | MP0003828_pulmonary_edema | 1.27368765 |
62 | MP0001958_emphysema | 1.26647241 |
63 | MP0005083_abnormal_biliary_tract | 1.25521707 |
64 | MP0002796_impaired_skin_barrier | 1.19583940 |
65 | MP0003656_abnormal_erythrocyte_physiolo | 1.19384457 |
66 | MP0001835_abnormal_antigen_presentation | 1.18949027 |
67 | MP0002060_abnormal_skin_morphology | 1.18773338 |
68 | MP0001800_abnormal_humoral_immune | 1.17000336 |
69 | MP0002722_abnormal_immune_system | 1.15961118 |
70 | MP0003763_abnormal_thymus_physiology | 1.15755111 |
71 | MP0005390_skeleton_phenotype | 1.12564724 |
72 | MP0002998_abnormal_bone_remodeling | 1.11935384 |
73 | MP0005248_abnormal_Harderian_gland | 1.10750449 |
74 | MP0002723_abnormal_immune_serum | 1.08283875 |
75 | MP0003191_abnormal_cellular_cholesterol | 1.08236529 |
76 | MP0001790_abnormal_immune_system | 1.07491316 |
77 | MP0005387_immune_system_phenotype | 1.07491316 |
78 | MP0002009_preneoplasia | 1.07403039 |
79 | MP0003866_abnormal_defecation | 1.07355938 |
80 | MP0003806_abnormal_nucleotide_metabolis | 1.05209066 |
81 | MP0002282_abnormal_trachea_morphology | 1.01440076 |
82 | MP0009840_abnormal_foam_cell | 1.01376407 |
83 | MP0009765_abnormal_xenobiotic_induced | 1.00131680 |
84 | MP0003705_abnormal_hypodermis_morpholog | 0.98633543 |
85 | MP0009333_abnormal_splenocyte_physiolog | 0.95577289 |
86 | MP0008469_abnormal_protein_level | 0.94955465 |
87 | MP0002138_abnormal_hepatobiliary_system | 0.94346781 |
88 | MP0005621_abnormal_cell_physiology | 0.93947047 |
89 | MP0002277_abnormal_respiratory_mucosa | 0.93925501 |
90 | * MP0000689_abnormal_spleen_morphology | 0.91268093 |
91 | MP0000716_abnormal_immune_system | 0.90135106 |
92 | MP0000579_abnormal_nail_morphology | 0.89734415 |
93 | MP0002396_abnormal_hematopoietic_system | 0.88946940 |
94 | MP0000627_abnormal_mammary_gland | 0.88167806 |
95 | MP0005058_abnormal_lysosome_morphology | 0.87904204 |
96 | MP0009763_increased_sensitivity_to | 0.87285514 |
97 | MP0004185_abnormal_adipocyte_glucose | 0.85633125 |
98 | MP0000703_abnormal_thymus_morphology | 0.84235911 |
99 | MP0001873_stomach_inflammation | 0.83925282 |
100 | MP0006082_CNS_inflammation | 0.83219842 |
101 | MP0002133_abnormal_respiratory_system | 0.81337631 |
102 | MP0005388_respiratory_system_phenotype | 0.81337631 |
103 | MP0002398_abnormal_bone_marrow | 0.80943338 |
104 | MP0001663_abnormal_digestive_system | 0.79737370 |
105 | MP0005310_abnormal_salivary_gland | 0.77509270 |
106 | MP0000377_abnormal_hair_follicle | 0.77106377 |
107 | MP0009931_abnormal_skin_appearance | 0.76497098 |
108 | MP0003690_abnormal_glial_cell | 0.75876261 |
109 | MP0009115_abnormal_fat_cell | 0.75319781 |
110 | MP0005666_abnormal_adipose_tissue | 0.75038480 |
111 | MP0000490_abnormal_crypts_of | 0.74313229 |
112 | MP0002429_abnormal_blood_cell | 0.73988259 |
113 | MP0002006_tumorigenesis | 0.73388510 |
114 | MP0000537_abnormal_urethra_morphology | 0.73108482 |
115 | MP0005535_abnormal_body_temperature | 0.72850728 |
116 | MP0005409_darkened_coat_color | 0.71899340 |
117 | MP0003045_fibrosis | 0.71792880 |
118 | MP0000920_abnormal_myelination | 0.71232143 |
119 | MP0002098_abnormal_vibrissa_morphology | 0.70845782 |
120 | MP0005501_abnormal_skin_physiology | 0.70554986 |
121 | MP0002971_abnormal_brown_adipose | 0.69340050 |
122 | MP0000249_abnormal_blood_vessel | 0.67955896 |
123 | MP0003638_abnormal_response/metabolism_ | 0.67416271 |
124 | MP0004381_abnormal_hair_follicle | 0.66724341 |
125 | MP0010771_integument_phenotype | 0.66021501 |
126 | * MP0000609_abnormal_liver_physiology | 0.65870876 |
127 | MP0003795_abnormal_bone_structure | 0.63469524 |
128 | MP0003172_abnormal_lysosome_physiology | 0.62901569 |
129 | MP0001191_abnormal_skin_condition | 0.61080654 |
130 | MP0005671_abnormal_response_to | 0.60621563 |
131 | MP0005334_abnormal_fat_pad | 0.57642786 |
132 | MP0008004_abnormal_stomach_pH | 0.57095251 |
133 | MP0005165_increased_susceptibility_to | 0.56938015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 8.48046018 |
2 | Recurrent abscess formation (HP:0002722) | 7.84951484 |
3 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.70644920 |
4 | Recurrent bacterial skin infections (HP:0005406) | 6.83388013 |
5 | Hypochromic microcytic anemia (HP:0004840) | 5.43110568 |
6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.28666738 |
7 | Abnormality of macrophages (HP:0004311) | 5.28337928 |
8 | Gingivitis (HP:0000230) | 5.01240915 |
9 | Systemic lupus erythematosus (HP:0002725) | 4.93947225 |
10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.78736145 |
11 | Obstructive lung disease (HP:0006536) | 4.78736145 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 4.58292822 |
13 | Pustule (HP:0200039) | 4.48111524 |
14 | Poikilocytosis (HP:0004447) | 4.27973950 |
15 | Onycholysis (HP:0001806) | 4.04024729 |
16 | Cellulitis (HP:0100658) | 3.99638817 |
17 | Urticaria (HP:0001025) | 3.98015495 |
18 | Recurrent fungal infections (HP:0002841) | 3.90045415 |
19 | Hypochromic anemia (HP:0001931) | 3.76811126 |
20 | Recurrent skin infections (HP:0001581) | 3.64227214 |
21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.63039318 |
22 | Interstitial pulmonary disease (HP:0006530) | 3.55848561 |
23 | Milia (HP:0001056) | 3.52109213 |
24 | Stomatitis (HP:0010280) | 3.50602276 |
25 | Right ventricular cardiomyopathy (HP:0011663) | 3.31071422 |
26 | Atrophic scars (HP:0001075) | 3.09754492 |
27 | Microcytic anemia (HP:0001935) | 3.04211338 |
28 | Abnormality of iron homeostasis (HP:0011031) | 3.03439209 |
29 | Gastrointestinal infarctions (HP:0005244) | 3.02918358 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.96600716 |
31 | Abnormality of B cell number (HP:0010975) | 2.95036109 |
32 | Polycythemia (HP:0001901) | 2.94731363 |
33 | Abnormality of the fingertips (HP:0001211) | 2.94290227 |
34 | Myositis (HP:0100614) | 2.93222135 |
35 | Increased serum ferritin (HP:0003281) | 2.91836415 |
36 | Autoimmune thrombocytopenia (HP:0001973) | 2.85071591 |
37 | Amyloidosis (HP:0011034) | 2.81681129 |
38 | Skin ulcer (HP:0200042) | 2.77949112 |
39 | Abnormal platelet volume (HP:0011876) | 2.77653885 |
40 | Anorexia (HP:0002039) | 2.75517596 |
41 | Fragile nails (HP:0001808) | 2.71102858 |
42 | Meningitis (HP:0001287) | 2.68681001 |
43 | B lymphocytopenia (HP:0010976) | 2.63339061 |
44 | Periodontitis (HP:0000704) | 2.63075658 |
45 | Cheilitis (HP:0100825) | 2.59187761 |
46 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.58283134 |
47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.57999016 |
48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.57999016 |
49 | Increased mean platelet volume (HP:0011877) | 2.51263586 |
50 | Curly hair (HP:0002212) | 2.47779073 |
51 | Osteomyelitis (HP:0002754) | 2.45518708 |
52 | Pili torti (HP:0003777) | 2.45114812 |
53 | Granulocytopenia (HP:0001913) | 2.44029530 |
54 | Abnormality of sodium homeostasis (HP:0010931) | 2.43824579 |
55 | Toxemia of pregnancy (HP:0100603) | 2.43771343 |
56 | Vacuolated lymphocytes (HP:0001922) | 2.42419473 |
57 | Abnormal hemoglobin (HP:0011902) | 2.40873357 |
58 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40599893 |
59 | Difficulty running (HP:0009046) | 2.38250259 |
60 | Slow saccadic eye movements (HP:0000514) | 2.36503186 |
61 | Papilledema (HP:0001085) | 2.36147010 |
62 | Hemoptysis (HP:0002105) | 2.35719908 |
63 | Thickened calvaria (HP:0002684) | 2.35476904 |
64 | Retrobulbar optic neuritis (HP:0100654) | 2.33007947 |
65 | Optic neuritis (HP:0100653) | 2.33007947 |
66 | Nasal polyposis (HP:0100582) | 2.31133384 |
67 | Sepsis (HP:0100806) | 2.31123044 |
68 | Pulmonary infiltrates (HP:0002113) | 2.29990726 |
69 | Polygenic inheritance (HP:0010982) | 2.29972649 |
70 | Muscle fiber splitting (HP:0003555) | 2.28541173 |
71 | Increased connective tissue (HP:0009025) | 2.25495555 |
72 | Scanning speech (HP:0002168) | 2.24874499 |
73 | Short femoral neck (HP:0100864) | 2.24158601 |
74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22390628 |
75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22390628 |
76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22390628 |
77 | Ulnar bowing (HP:0003031) | 2.22162495 |
78 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.19945620 |
79 | Orchitis (HP:0100796) | 2.19233415 |
80 | Diaphragmatic weakness (HP:0009113) | 2.18634216 |
81 | Vascular calcification (HP:0004934) | 2.16097503 |
82 | Glomerulonephritis (HP:0000099) | 2.16057384 |
83 | Alopecia of scalp (HP:0002293) | 2.15209201 |
84 | Pyloric stenosis (HP:0002021) | 2.14522529 |
85 | Hepatosplenomegaly (HP:0001433) | 2.14490215 |
86 | Petechiae (HP:0000967) | 2.13190147 |
87 | Abnormality of the nasal mucosa (HP:0000433) | 2.11931732 |
88 | Plantar hyperkeratosis (HP:0007556) | 2.10867864 |
89 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07957730 |
90 | Cardiovascular calcification (HP:0011915) | 2.07323340 |
91 | Recurrent viral infections (HP:0004429) | 2.06463641 |
92 | Spontaneous hematomas (HP:0007420) | 2.06108942 |
93 | Metaphyseal irregularity (HP:0003025) | 2.04107437 |
94 | Increased cerebral lipofuscin (HP:0011813) | 2.02763587 |
95 | Prolonged bleeding time (HP:0003010) | 2.01642455 |
96 | Gout (HP:0001997) | 2.01256678 |
97 | Episodic fever (HP:0001954) | 1.99110529 |
98 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.98717997 |
99 | Abnormal blistering of the skin (HP:0008066) | 1.98160993 |
100 | Autoimmune hemolytic anemia (HP:0001890) | 1.97300316 |
101 | Vasculitis (HP:0002633) | 1.96951946 |
102 | Axonal loss (HP:0003447) | 1.96812404 |
103 | Myocardial infarction (HP:0001658) | 1.95256248 |
104 | Hematochezia (HP:0002573) | 1.94669526 |
105 | Hypoplasia of dental enamel (HP:0006297) | 1.94469763 |
106 | Paralysis (HP:0003470) | 1.94167687 |
107 | Metaphyseal cupping (HP:0003021) | 1.92724374 |
108 | Obstructive sleep apnea (HP:0002870) | 1.91294674 |
109 | Nephritis (HP:0000123) | 1.90170309 |
110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89962448 |
111 | Verrucae (HP:0200043) | 1.89149733 |
112 | Papilloma (HP:0012740) | 1.89149733 |
113 | Gingival bleeding (HP:0000225) | 1.84875834 |
114 | Peritonitis (HP:0002586) | 1.84762290 |
115 | Nail dystrophy (HP:0008404) | 1.83022074 |
116 | Cholelithiasis (HP:0001081) | 1.83008165 |
117 | Abnormality of oral frenula (HP:0000190) | 1.82506174 |
118 | Ocular albinism (HP:0001107) | 1.82223860 |
119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.81830312 |
120 | Hypertriglyceridemia (HP:0002155) | 1.80378318 |
121 | Abnormality of complement system (HP:0005339) | 1.80185119 |
122 | Cone-rod dystrophy (HP:0000548) | 1.80002647 |
123 | Abnormal foot bone ossification (HP:0010675) | 1.79814249 |
124 | Acute myeloid leukemia (HP:0004808) | 1.79593196 |
125 | Hypergammaglobulinemia (HP:0010702) | 1.79295879 |
126 | Leukocytosis (HP:0001974) | 1.78825101 |
127 | Skin rash (HP:0000988) | 1.78351018 |
128 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78036968 |
129 | Keratoconjunctivitis sicca (HP:0001097) | 1.77930431 |
130 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.77378222 |
131 | Eosinophilia (HP:0001880) | 1.77290572 |
132 | Chronic otitis media (HP:0000389) | 1.76470023 |
133 | Purpura (HP:0000979) | 1.76403128 |
134 | Ankyloglossia (HP:0010296) | 1.75438591 |
135 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.75373947 |
136 | Increased IgE level (HP:0003212) | 1.74336280 |
137 | Recurrent pneumonia (HP:0006532) | 1.74222617 |
138 | Osteolytic defects of the hand bones (HP:0009699) | 1.74129993 |
139 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.74129993 |
140 | Reticulocytosis (HP:0001923) | 1.71637172 |
141 | Fatigue (HP:0012378) | 1.70534104 |
142 | Inflammation of the large intestine (HP:0002037) | 1.70041871 |
143 | Absent frontal sinuses (HP:0002688) | 1.67778620 |
144 | Dysostosis multiplex (HP:0000943) | 1.65800366 |
145 | Bowed forearm bones (HP:0003956) | 1.64527814 |
146 | Bowing of the arm (HP:0006488) | 1.64527814 |
147 | Subacute progressive viral hepatitis (HP:0006572) | 1.63719784 |
148 | Epistaxis (HP:0000421) | 1.63229849 |
149 | Menorrhagia (HP:0000132) | 1.62011998 |
150 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.61994498 |
151 | Glomerulosclerosis (HP:0000096) | 1.60806878 |
152 | Chest pain (HP:0100749) | 1.60796809 |
153 | Hypermelanotic macule (HP:0001034) | 1.59695457 |
154 | Gastrointestinal inflammation (HP:0004386) | 1.59328851 |
155 | IgM deficiency (HP:0002850) | 1.59164463 |
156 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.57268545 |
157 | Persistence of primary teeth (HP:0006335) | 1.56652217 |
158 | Arterial tortuosity (HP:0005116) | 1.55778253 |
159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.54559221 |
160 | Keratoconjunctivitis (HP:0001096) | 1.54172444 |
161 | Cervical subluxation (HP:0003308) | 1.53929700 |
162 | Hemorrhage of the eye (HP:0011885) | 1.53021327 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 5.29769055 |
2 | PRPF4B | 4.24331219 |
3 | TRPM7 | 4.15875902 |
4 | EPHB1 | 4.03155834 |
5 | MAP3K6 | 3.93677290 |
6 | ERBB3 | 3.82419414 |
7 | IRAK4 | 3.49747695 |
8 | MAP3K9 | 2.84436244 |
9 | ERN1 | 2.47356447 |
10 | TRIB3 | 2.29537877 |
11 | PIK3CG | 2.26734905 |
12 | CSK | 2.16555161 |
13 | IRAK1 | 2.16355422 |
14 | PTK6 | 2.08697777 |
15 | RIPK4 | 2.07364136 |
16 | PTK2 | 2.06613160 |
17 | FGR | 2.04016339 |
18 | STK10 | 1.94399327 |
19 | PAK4 | 1.93274658 |
20 | BLK | 1.90449532 |
21 | FRK | 1.88252192 |
22 | TTN | 1.81846742 |
23 | MAP2K3 | 1.80774971 |
24 | MAP3K12 | 1.75639992 |
25 | GRK6 | 1.75541168 |
26 | BTK | 1.73006555 |
27 | PKN2 | 1.71419948 |
28 | MAP3K3 | 1.65919703 |
29 | LRRK2 | 1.65803945 |
30 | ZAP70 | 1.54067261 |
31 | TNK2 | 1.50873058 |
32 | HCK | 1.49821709 |
33 | PIK3CA | 1.48137551 |
34 | CDK12 | 1.45712135 |
35 | TESK1 | 1.43928235 |
36 | FES | 1.42959132 |
37 | TAOK2 | 1.41075843 |
38 | KSR2 | 1.40997394 |
39 | CLK1 | 1.38819704 |
40 | TESK2 | 1.32153620 |
41 | RIPK1 | 1.29747470 |
42 | SIK3 | 1.27813064 |
43 | TGFBR2 | 1.21055465 |
44 | PRKG2 | 1.19932145 |
45 | MARK2 | 1.16161282 |
46 | IRAK2 | 1.15858937 |
47 | MAP3K2 | 1.15105705 |
48 | TEC | 1.11413507 |
49 | MST4 | 1.11359471 |
50 | FER | 1.07202502 |
51 | IKBKE | 1.00038324 |
52 | ALK | 0.97437053 |
53 | EPHA3 | 0.96954441 |
54 | BRSK2 | 0.93984768 |
55 | MAP2K4 | 0.93448912 |
56 | MATK | 0.93201692 |
57 | TAOK1 | 0.91706034 |
58 | MAP3K5 | 0.91215578 |
59 | KDR | 0.89629276 |
60 | HIPK2 | 0.89122065 |
61 | MARK3 | 0.88901349 |
62 | TYK2 | 0.87652775 |
63 | MST1R | 0.87320198 |
64 | JAK3 | 0.80929405 |
65 | MAP4K1 | 0.77216578 |
66 | NLK | 0.76432638 |
67 | KIT | 0.74856611 |
68 | BMPR2 | 0.71972183 |
69 | ITK | 0.71637271 |
70 | BMX | 0.71169863 |
71 | MAP3K1 | 0.70806514 |
72 | YES1 | 0.70619328 |
73 | SIK1 | 0.67491384 |
74 | MAPK12 | 0.65627280 |
75 | EPHB2 | 0.64748587 |
76 | AKT3 | 0.62926328 |
77 | STK4 | 0.62628322 |
78 | CAMK1D | 0.61577121 |
79 | EGFR | 0.59724457 |
80 | PDGFRB | 0.59410228 |
81 | FGFR3 | 0.59304903 |
82 | RAF1 | 0.59263157 |
83 | FYN | 0.57361831 |
84 | PTK2B | 0.55898881 |
85 | SMG1 | 0.55285332 |
86 | MAP3K13 | 0.54867987 |
87 | PRKD2 | 0.54139121 |
88 | SGK2 | 0.53629533 |
89 | IKBKB | 0.53481528 |
90 | MTOR | 0.53042197 |
91 | MAP3K11 | 0.52995733 |
92 | IRAK3 | 0.52968689 |
93 | SIK2 | 0.52845908 |
94 | MAP3K8 | 0.52633352 |
95 | MAP2K6 | 0.51940324 |
96 | TBK1 | 0.51889318 |
97 | DMPK | 0.51834496 |
98 | LCK | 0.50380518 |
99 | FGFR1 | 0.49902306 |
100 | EEF2K | 0.49898560 |
101 | CSF1R | 0.47835366 |
102 | MAPK4 | 0.47471440 |
103 | CAMK1G | 0.46842446 |
104 | FGFR4 | 0.45308473 |
105 | JAK2 | 0.44866816 |
106 | TXK | 0.44727833 |
107 | ABL1 | 0.44600047 |
108 | MAP2K1 | 0.43754970 |
109 | SRC | 0.43512522 |
110 | PRKCD | 0.42849903 |
111 | MAP2K2 | 0.39636084 |
112 | MAPKAPK2 | 0.39609621 |
113 | PAK3 | 0.38477582 |
114 | MAPK7 | 0.38451875 |
115 | SGK3 | 0.37799222 |
116 | BRD4 | 0.37094723 |
117 | MAP3K14 | 0.36159423 |
118 | PDPK1 | 0.36104401 |
119 | LIMK1 | 0.35885663 |
120 | GRK1 | 0.35231446 |
121 | RPS6KA2 | 0.34732546 |
122 | KSR1 | 0.34665002 |
123 | CDK6 | 0.34214993 |
124 | STK11 | 0.33635077 |
125 | MAPK11 | 0.32808756 |
126 | RPS6KL1 | 0.32607179 |
127 | RPS6KC1 | 0.32607179 |
128 | CHUK | 0.32490799 |
129 | RPS6KA6 | 0.31711394 |
130 | SYK | 0.29665516 |
131 | IGF1R | 0.29484662 |
132 | ERBB2 | 0.28827673 |
133 | RPS6KA4 | 0.28498847 |
134 | LYN | 0.27980346 |
135 | PRKAA2 | 0.27909643 |
136 | RET | 0.27815959 |
137 | RPS6KA1 | 0.27587088 |
138 | PRKCH | 0.25659864 |
139 | JAK1 | 0.23966378 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.30017464 |
2 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 3.22265441 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86555038 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.72498189 |
5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.04301733 |
6 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.01605382 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96910215 |
8 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.94982506 |
9 | Shigellosis_Homo sapiens_hsa05131 | 1.93992360 |
10 | Galactose metabolism_Homo sapiens_hsa00052 | 1.85976129 |
11 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75048684 |
12 | Pertussis_Homo sapiens_hsa05133 | 1.73049027 |
13 | Bladder cancer_Homo sapiens_hsa05219 | 1.69067753 |
14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62197890 |
15 | Amoebiasis_Homo sapiens_hsa05146 | 1.59446802 |
16 | Tuberculosis_Homo sapiens_hsa05152 | 1.58555813 |
17 | Adherens junction_Homo sapiens_hsa04520 | 1.54016479 |
18 | Salmonella infection_Homo sapiens_hsa05132 | 1.51207295 |
19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.49652934 |
20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43882615 |
21 | Platelet activation_Homo sapiens_hsa04611 | 1.41436929 |
22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.40470418 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38544353 |
24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.38264072 |
25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34149279 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32707643 |
27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.27110695 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25822435 |
29 | Phagosome_Homo sapiens_hsa04145 | 1.25794039 |
30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25335056 |
31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19808772 |
32 | Focal adhesion_Homo sapiens_hsa04510 | 1.18070159 |
33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17363283 |
34 | Asthma_Homo sapiens_hsa05310 | 1.15822564 |
35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13880034 |
36 | Legionellosis_Homo sapiens_hsa05134 | 1.13596334 |
37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11636223 |
38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09549852 |
39 | Malaria_Homo sapiens_hsa05144 | 1.08146339 |
40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07228739 |
41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06869228 |
42 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06363515 |
43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06209401 |
44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05705596 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03651204 |
46 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99005839 |
47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98881843 |
48 | Insulin resistance_Homo sapiens_hsa04931 | 0.98423579 |
49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94836055 |
50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92823529 |
51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88396801 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.87420178 |
53 | Prostate cancer_Homo sapiens_hsa05215 | 0.87342095 |
54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87073466 |
55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86482972 |
56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86148716 |
57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85340034 |
58 | Hepatitis B_Homo sapiens_hsa05161 | 0.85325864 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85014887 |
60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84919083 |
61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84483221 |
62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84341682 |
63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83261934 |
64 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83070887 |
65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82524996 |
66 | Salivary secretion_Homo sapiens_hsa04970 | 0.82231040 |
67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82130079 |
68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80356219 |
69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79772612 |
70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78313627 |
71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78226013 |
72 | Endocytosis_Homo sapiens_hsa04144 | 0.77516154 |
73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77455404 |
74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76724433 |
75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76098685 |
76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75944813 |
77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75782119 |
78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75766636 |
79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73786014 |
80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73386126 |
81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73250663 |
82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71817752 |
83 | Measles_Homo sapiens_hsa05162 | 0.71542566 |
84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71329048 |
85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71020756 |
86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70477792 |
87 | Tight junction_Homo sapiens_hsa04530 | 0.67727302 |
88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67617351 |
89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67528645 |
90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66519909 |
91 | Apoptosis_Homo sapiens_hsa04210 | 0.65471405 |
92 | Mineral absorption_Homo sapiens_hsa04978 | 0.64156649 |
93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63276587 |
94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62591495 |
95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.60722106 |
96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60093243 |
97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59803118 |
98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59780703 |
99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59747050 |
100 | Influenza A_Homo sapiens_hsa05164 | 0.59698834 |
101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59214167 |
102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59084197 |
103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59057252 |
104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57617601 |
105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56213685 |
106 | Lysosome_Homo sapiens_hsa04142 | 0.55887245 |
107 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55583889 |
108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54358174 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53710895 |
110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51312922 |
111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50841576 |
112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50114880 |
113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49582124 |
114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49232226 |
115 | Glioma_Homo sapiens_hsa05214 | 0.47898741 |
116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47572018 |
117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46769940 |
118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46682672 |
119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46246192 |
120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45928380 |
121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44709786 |
122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44651534 |
123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44567123 |
124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44462113 |
125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43802024 |
126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41781827 |
127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40688700 |